Share ownership Qiagen N.V.

QGEN

NL0015002CX3

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2025-11-10 pm EST			5-day change	1st Jan Change
43.17 ^USD	-0.90%		-5.49%	-5.75%

02:40am	QIAGEN NV : Buy rating from Berenberg	ZD
Nov. 10	QIAGEN N.V. Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025	CI

Share class: Qiagen N.V.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	217,683,947	211,237,625 ( 97.04 %)	1,601,246 ( 0.7356 %)	97.04 %

Major shareholders: Qiagen N.V.

Name	Equities	%	Valuation
Wellington Trust Co., NA 12 %	26,023,940	12 %	1 219 M $
MFS Investment Management Canada Ltd. 11.04 %	23,940,960	11.04 %	1 122 M $
Vanguard Fiduciary Trust Co. 4.333 %	9,394,473	4.333 %	440 M $
BlackRock Fund Advisors 2.931 %	6,354,931	2.931 %	298 M $
T. Rowe Price International Ltd. 2.738 %	5,936,065	2.738 %	278 M $
DWS Investment Management Americas, Inc. 2.483 %	5,384,592	2.483 %	252 M $
BlackRock Advisors LLC 2.424 %	5,256,915	2.424 %	246 M $
DWS Investment GmbH 2.129 %	4,615,877	2.129 %	216 M $
BlackRock Advisors (UK) Ltd. 2.04 %	4,423,311	2.04 %	207 M $
EARNEST Partners LLC 1.938 %	4,202,251	1.938 %	197 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	70.98%
Other	5.54%
Governments	1.07%
State Street Corp.	0.99%
SEI Investments Co.	0.84%
Individuals	0.49%
Schweizerische Nationalbank	0.3%
Sumitomo Mitsui Trust Group, Inc.	0.08%
Polar Capital Holdings Plc	0.07%
Manulife Financial Corp.	0.04%
Regions Financial Corp.	0.03%
Fifth Third Bancorp	0.03%
Banque Cantonale Vaudoise	0.01%
Unknown	19.53%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	45.04%
Canada	11.75%
United Kingdom	10.02%
Germany	5.81%
France	3.32%
Norway	1.6%
Switzerland	0.57%
Individuals	0.49%
Italy	0.47%
Sweden	0.37%
Spain	0.28%
Ireland	0.14%
Denmark	0.11%
South Korea	0.11%
Japan	0.09%
Luxembourg	0.09%
Finland	0.07%
Singapore	0.04%
Netherlands	0.03%
China	0.02%
Austria	0.02%
Hong Kong	0.01%
Liechtenstein	0.01%

Based on 1000 largest holdings

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Employees

5,700

Sector

Biotechnology & Medical Research

Calendar

Nov. 16 - Wolfe Research Healthcare Conference

More about the company